Literature DB >> 11130337

Radioactive contamination of contact lenses during radioiodine therapy.

G Zettinig1, G Karanikas, G Hanselmayer, E Havlik, R Dudczak.   

Abstract

Although the secretion of radioiodine in tears is not unexpected, there are only few investigations in that field. We report the measurement of 131I in disposable contact lenses for daily use during radioiodine treatment. After administration of 740 MBq 131I, all contact lenses of a 59-year-old female used the day before and 5 days after radioiodine therapy were collected and measured in a gamma counter. Activities of 124 Bq (right) and 139 Bq (left) were measured in the contact lenses used during the first day after administration of radioiodine. The activity in the contact lenses of the following days was significantly lower. An initial dose rate of approximately 0.31 microSv x h(-1) was caused by the radioactivity resulting in a total dose of 13 microSv to the patient's eye lens. That dose is negligible compared to the dose caused by the incorporated radioactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130337     DOI: 10.1097/00006231-200010000-00010

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.

Authors:  Jacqueline Jonklaas
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

2.  Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy.

Authors:  Jacqueline Jonklaas; Hong Wang; Giuseppe Esposito
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-17       Impact factor: 5.555

3.  Radioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body I-131 Imaging: A Case Series.

Authors:  Pelin Ozcan Kara; Emel Ceylan Gunay; Alihan Erdogan
Journal:  Int J Endocrinol Metab       Date:  2014-01-01

Review 4.  Radioactive Iodine Therapy and Glucose Tolerance.

Authors:  Roghaieh Samadi; Babak Shafiei; Fereidoun Azizi; Asghar Ghasemi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.